Buoyant Bob

In May 2026, Buoyant Bob concentrated 57.24% of sales in Vapor Pens with a month-over-month rise of 15.83% but a year-over-year decline of 2.47%, while Flower held 21.87% share with a modest 2.89% MoM lift against a steep 42.15% YoY drop. Concentrates expanded to 12.91% share on a 28.06% MoM increase and 24.77% YoY growth, whereas Pre-Roll at 7.41% share climbed 21.83% MoM but fell 28.70% YoY; Edible shrank to 0.58% share with a 53.67% MoM decline and a 57.96% YoY fall. With average price up 4.40% YoY to $26.63 and overall brand sales down 15.68% YoY, the mix shows reliance on Vapor Pens for near-term volume recovery alongside a pivot toward Concentrates as the only category with both MoM and YoY gains, implying category rebalance is doing more work than pricing for May 2026 momentum.

These shifts position Buoyant Bob toward higher-ticket inhalables: Vapor Pens’ 57.24% share and rank 14 in Vapor Pens in Missouri create headroom to trade up even as Flower’s 42.15% YoY contraction reduces low-margin breadth, and Pre-Roll’s 21.83% MoM bump offers episodic traffic rather than durable share. Concentrates’ 24.77% YoY growth alongside a 28.06% MoM surge signals a viable second pillar that can offset Flower and Edible declines of 42.15% and 57.96% YoY respectively, so the near-term positioning thesis is to lean into Vapor Pens and Concentrates to stabilize share while treating Flower and Edible as loss-mitigation categories.